ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 670312 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 670312; 2) Community: the network communities that were significantly associated with the response to NSC 670312; 3) Molecule: the relationships between components within communities and NSC 670312; 4) MDR: the compounds that were significantly associated with the NSC 670312.

NSC Compound Enrichment Correlation
NSC 722854 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline 0.0430505868034761 0.49952854
NSC 722867 Null 0.0430505868034761 0.26513649
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.0430505868034761 0.27306293
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0430505868034761 0.14277803
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0430505868034761 0.32348018
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0430505868034761 0.31902686
NSC 735030 Null 0.0430505868034761 0.39614538
NSC 737231 Null 0.0430505868034761 0.50159311
NSC 740 Methotrexate 0.0430505868034761 0.14745663
NSC 744063 Null 0.0430505868034761 0.33283525
Total:154  Current:135    [First] [Prev] [Next] [Last]